Literature DB >> 15546588

Increased incidence of the Hfe mutation in amyotrophic lateral sclerosis and related cellular consequences.

Xin-Sheng Wang1, Sang Lee, Zachary Simmons, Philip Boyer, Kevin Scott, Wenlei Liu, James Connor.   

Abstract

The etiology of amyotrophic lateral sclerosis (ALS) is unknown. The presence of mutations in the superoxide dismutase gene (SOD1) has led to theories regarding a role for oxidative stress in the pathogenesis of this disease. A primary cause of oxidative stress is perturbations in cellular iron homeostasis. Cellular iron mismanagement and oxidative stress are associated with a number of neurodegenerative diseases. One mechanism by which cells fail to properly regulate their iron status is through a mutation in the Hfe gene. Mutations in the Hfe gene are associated with the iron overload disease, hemochromatosis. In the current study, 31% of patients with sporadic ALS carried a mutation in the Hfe gene, compared to only 14% of patients without identifiable neuromuscular disease, or with neuromuscular diseases other than ALS (p<0.005). To determine the cellular consequences of carrying an Hfe mutation, a human neuronal cell line was transfected with genes carrying the Hfe mutation. The presence of the Hfe mutation disrupted expression of tubulin and actin at the protein levels potentially consistent with the disruption of axonal transport seen in ALS and was also associated with a decrease in CuZnSOD1 expression. These data provide compelling evidence for a role for the Hfe mutation in etiopathogenesis of ALS and warrant further investigation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15546588     DOI: 10.1016/j.jns.2004.08.003

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  25 in total

1.  HFE H63D polymorphism is increased in patients with amyotrophic lateral sclerosis of Italian origin.

Authors:  G Restagno; F Lombardo; P Ghiglione; A Calvo; E Cocco; L Sbaiz; R Mutani; A Chiò
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03       Impact factor: 10.154

2.  Effect of HFE variants on sphingolipid expression by SH-SY5Y human neuroblastoma cells.

Authors:  F Ali-Rahmani; J A Hengst; J R Connor; C-L Schengrund
Journal:  Neurochem Res       Date:  2011-01-18       Impact factor: 3.996

Review 3.  Clinical genetics of amyotrophic lateral sclerosis: what do we really know?

Authors:  Peter M Andersen; Ammar Al-Chalabi
Journal:  Nat Rev Neurol       Date:  2011-10-11       Impact factor: 42.937

4.  Mutant HFE H63D protein is associated with prolonged endoplasmic reticulum stress and increased neuronal vulnerability.

Authors:  Yiting Liu; Sang Y Lee; Elizabeth Neely; Wint Nandar; Mthabisi Moyo; Zachary Simmons; James R Connor
Journal:  J Biol Chem       Date:  2011-02-24       Impact factor: 5.157

Review 5.  Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.

Authors:  D Allan Butterfield; Marzia Perluigi; Tanea Reed; Tasneem Muharib; Christopher P Hughes; Renã A S Robinson; Rukhsana Sultana
Journal:  Antioxid Redox Signal       Date:  2012-01-18       Impact factor: 8.401

6.  Increased serum ferritin levels in amyotrophic lateral sclerosis (ALS) patients.

Authors:  E F Goodall; M S Haque; K E Morrison
Journal:  J Neurol       Date:  2008-07-18       Impact factor: 4.849

7.  Statins accelerate disease progression and shorten survival in SOD1(G93A) mice.

Authors:  Xiaowei W Su; Wint Nandar; Elizabeth B Neely; Zachary Simmons; James R Connor
Journal:  Muscle Nerve       Date:  2016-05-19       Impact factor: 3.217

8.  Iron-mediated inhibition of mitochondrial manganese uptake mediates mitochondrial dysfunction in a mouse model of hemochromatosis.

Authors:  Hani A Jouihan; Paul A Cobine; Robert C Cooksey; Emily A Hoagland; Sihem Boudina; E Dale Abel; Dennis R Winge; Donald A McClain
Journal:  Mol Med       Date:  2008 Mar-Apr       Impact factor: 6.354

9.  Expression of iron-related genes in human brain and brain tumors.

Authors:  Milla M Hänninen; Joonas Haapasalo; Hannu Haapasalo; Robert E Fleming; Robert S Britton; Bruce R Bacon; Seppo Parkkila
Journal:  BMC Neurosci       Date:  2009-04-22       Impact factor: 3.288

10.  Serum ferritin and metal levels as risk factors for amyotrophic lateral sclerosis.

Authors:  Muddasir Qureshi; Robert H Brown; Jack T Rogers; Merit E Cudkowicz
Journal:  Open Neurol J       Date:  2008-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.